When treated with isoform-specific PLD inhibitors, the viability of MDA-MB-231 breast cancer cells grown in the regular culture medium that contained high glucose (25 mM) was not significantly altered by either the PLD1 inhibitor (PLD1i) or PLD2 inhibitor (PLD2i) (Figure 1a). The gene discussed is PLD2; the disease is breast carcinoma.